IRIS
MARTINI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.359
EU - Europa 5.020
AS - Asia 786
SA - Sud America 16
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 3
Totale 11.201
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.332
GB - Regno Unito 1.155
IE - Irlanda 1.008
IT - Italia 738
SE - Svezia 646
CN - Cina 624
UA - Ucraina 471
DE - Germania 432
FR - Francia 302
FI - Finlandia 140
VN - Vietnam 62
ES - Italia 37
TR - Turchia 33
CA - Canada 23
BE - Belgio 21
IN - India 19
RU - Federazione Russa 19
IR - Iran 16
GR - Grecia 11
AU - Australia 10
NL - Olanda 10
CL - Cile 7
PL - Polonia 7
BR - Brasile 6
CH - Svizzera 6
EU - Europa 6
SG - Singapore 6
BD - Bangladesh 4
KR - Corea 4
AT - Austria 3
BG - Bulgaria 3
HK - Hong Kong 3
JP - Giappone 3
AR - Argentina 2
BB - Barbados 2
IQ - Iraq 2
MY - Malesia 2
PH - Filippine 2
RO - Romania 2
SI - Slovenia 2
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 11.201
Salva come PNG Salva come JPEG
Città #
Southend 1.045
Dublin 982
Fairfield 862
Chandler 495
Ashburn 446
Jacksonville 373
Woodbridge 368
Seattle 334
Wilmington 326
Houston 284
Cambridge 266
Ann Arbor 225
Princeton 206
Siena 203
Beijing 139
Nanjing 125
Dearborn 93
San Diego 78
Vimercate 78
Helsinki 68
Dong Ket 61
Boardman 59
Menlo Park 52
Nanchang 42
Shanghai 41
Milan 38
New York 35
Shenyang 35
Tianjin 35
Florence 32
Málaga 31
San Mateo 30
Hebei 28
Kunming 28
Izmir 27
London 24
Jiaxing 21
Brussels 19
Redwood City 19
Mestre 18
Washington 17
Toronto 16
Jinan 15
Norwalk 15
Rome 14
Arezzo 13
Hangzhou 13
Prato 12
San Francisco 12
Zhengzhou 12
Changsha 11
Fremont 11
Ningbo 11
Taizhou 11
Hefei 10
Lancaster 9
Düsseldorf 8
Kilburn 7
Nicola 7
Philadelphia 7
Pune 7
Saronno 7
Bonndorf 6
Codogno 6
Falls Church 6
Lanzhou 6
Livorno 6
Perugia 6
Venezia 6
Zanjan 6
Casalzuigno 5
Hounslow 5
Islington 5
Melbourne 5
Santiago 5
Auburn Hills 4
Bologna 4
Campi Bisenzio 4
Chongqing 4
Guangzhou 4
Palermo 4
Paris 4
Renton 4
Rossendale 4
Sacramento 4
Sevilla 4
Warsaw 4
Bagni Di Lucca 3
Belvedere Marittimo 3
Canzo 3
Chengdu 3
Chittagong 3
Frankfurt am Main 3
Haikou 3
Jinhua 3
Lamezia Terme 3
Leawood 3
Los Angeles 3
Mountain View 3
Mumbai 3
Totale 8.076
Salva come PNG Salva come JPEG
Nome #
null 398
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 222
Systemic thrombolysis for stroke in pregnancy 193
Autonomic activity and baroreflex sensitivity in patients submitted to carotid stenting. 179
Homocysteinemia control by cysteine in cerebral vascular patients after methionine loading test: evidences in physiological and pathological conditions in cerebro-vascular and multiple sclerosis patients 172
Endovascular treatment of early recurrent ischemic stroke following intravenous thrombolysis 172
Choreoathetosis associated with non-chetotic hyperglycemia 171
The THRombolysis and STatins (THRaST) study 167
Predictors of long-term recovery in complex activities of daily living before discharge from the stroke unit 164
First report of an Iraqi Kurdish CADASIL patient. 164
Thrombolytic treatment of cardiac myxoma-induced ischemic stroke: a review 157
Stroke warning syndrome: 18 new cases. 156
Double ophthalmic arteries arising from the internal carotid artery. A case report of a hidden second ophthalmic artery 154
Safety of intravenous thrombolysis in ischemic stroke caused by left atrial myxoma 151
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 150
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial 147
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone 144
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 144
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 144
Neuroimaging and definition of transient ischemic attack 142
Wake-up (or wake-up for) stroke: a treatable stroke. 140
Characteristics and familial aggregation of Paget's disease of bone in Italy 140
Neuroimaging of transient ischemic attack 137
Expanding the phenotype of 22q11 deletion syndrome: the MURCS association 135
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone 133
Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study 132
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study. 130
Longitudinal association between sex hormone levels, bone loss and bone turnover in elderly men. 129
Long-Term Bone Density Evaluation in Cerebrotendinous Xanthomatosis: Evidence of Improvement after Chenodeoxycholic Acid Treatment. 129
Corretto uso dei marcatori del rimodellamento osseo 128
Manual thromboaspiration technique as a first approach for endovascular stroke treatment: A single-center experience 128
Relationship between the modified Rankin Scale and the Barthel Index in the process of functional recovery after stroke 128
Serum cholesterol levels, HMG-CoA reductase inhibitors and the risk of intracerebral haemorrhage. The Multicenter Study on Cerebral Haemorrhage in Italy (MUCH-Italy). 126
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone 125
null 124
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget’s disease of bone 123
Prevalence of Paget’s disease of bone in Italy 123
null 122
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study 122
Left ventricular hypertrophy differences in male professional runners and in young patients suffering from mild hypertension 121
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone 121
Teriparatide's effects on quantitative ultrasound parameters and bone density in women with established osteoporosis 120
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 119
Bazedoxifene for the prevention of postmenopausal osteoporosis 117
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study. 115
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 115
The effects of zoledronic acid on serum lipids in multiple myeloma patients 114
The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women 114
Ultrasonographic assessment of bone in normal Italian males and females 114
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family 112
Update on the pharmacogenetics of the vitamin D receptor and osteoporosis 110
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. 109
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature. 109
Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review 98
Does calcium supplementation reduce the risk of osteoporotic fracture and bone loss? 97
Paget’s disease of bone in Italy. 97
ESR study of metabolic characteristics of erythrocytes in the first hours of life 95
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis 94
Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure 94
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 89
Bone metabolism in men: role of aromatase activity 87
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 87
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study. 85
CALCITRIOLO E OSTEOPOROSI 84
The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma 82
Serum relaxin in systemic sclerosis 82
aromatase deficiency and male osteoporosis 81
Identification of Single Nucleotide Polymorphisms (SNPs) contributing to bone mineral density and fractures: a DNA microarray based study 80
Vitamin D and its metabolites in the pathogenesis and treatment of osteoporosis 78
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 78
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 74
Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy) 73
Possible pathogenetic role of antiphospholipid antibodies in a clinical case of human immunodeficiency virus infection with peripheral polyneuropathy and arterial thrombosis 72
Dilated cardiomyopathy secondary to idiopathic hypoparathyroidism in adults. Description of a case [Miocardiopatia dilatativa secondaria ad ipoparatiroidismo idiopatico dell'adulto. Descrizione di un caso] 71
The heart in ankylosing spondylitis [Coinvolgimento cardiaco nella spondilite anchilosante] 70
Appropriateness, safety, and effectiveness of “drip and ship” teleconsultation model in Southeastern Tuscany: a feasibility study 68
[Retention of 99mTc-MDP in edema fluid]. 67
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 66
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 65
Oncogenic osteomalacia 64
Is polymyalgia rheumatica caused by infectious agents? 61
null 61
Increased Arterial Stiffness is a Predictor of Delayed Ischaemic Stroke After Subarachnoid Haemorrhage 61
la genetica dell'osteoporosi 59
Increased arterial stiffness is associated with poor collaterals in acute ischemic stroke from large vessel occlusion 57
osteoporosi: clinica e terapia 56
Professional sport activity and micronutrients: effects on bone mass 55
PREvention of VENous Thromboembolism in Hemorrhagic Stroke Patients-PREVENTIHS Study: A Randomized Controlled Trial and a Systematic Review and Meta-Analysis 55
Age-dependent effect of susceptibility factors on the risk of intracerebral haemorrhage: Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy) 55
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 54
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 54
Acute ischemic stroke and concomitant massive pulmonary embolism: a challenge 52
Concurrent subarachnoid haemorrhage and internal carotid artery dissection: a transcranial colour-coded sonography diagnosis 52
Dual X-ray and laser absorptiometry of the calcaneus: comparison with quantitative ultrasound and dual-energy X-ray absorptiometry 51
Safety of Anticoagulation in Patients Treated with Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation 50
Inflammation and Atrial Electrical Remodelling in Patients With Embolic Strokes of Undetermined Source 50
Letter regarding “Combined aspiration thrombectomy and continuous intrasinus thrombolysis for cerebral venous sinus thrombosis: technical note and case series” 50
la microarchitettura ossea 49
Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development 46
Single-center experience using the 3MAX or 4MAX reperfusion catheter for the treatment of acute ischemic stroke with distal arterial occlusions in patients not eligible for intravenous fibrinolysis 46
Totale 10.807
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019749 0 0 0 0 0 0 0 0 0 168 303 278
2019/20202.286 267 83 151 346 138 232 250 282 158 209 54 116
2020/20211.735 85 166 55 153 69 150 79 241 287 121 177 152
2021/20221.722 146 150 43 232 70 43 44 135 132 155 230 342
2022/20232.000 128 180 287 252 175 392 70 147 183 55 93 38
2023/20241.355 66 23 154 69 68 400 508 43 9 15 0 0
Totale 11.415